Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Quesada, Anastasia
DOB: 09-APR-1955 (Age: 70)
Gender: female
Address:
Pasaje Eli Madrigal 26
26001 La Rioja (Spain)
ID: 7881-246905-0 (ECI)
Report
Date: 23-JUN-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Consultorio Médico
Calle de los Donantes de Sangre 3
26140 Lardero (Spain)
Specimen
Collected: 23-JUN-2017

Chemistry

Test 23-JUN-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.8 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 67.0 L 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 9.0 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.6 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Blood 136.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.6 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 107.8 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.2 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 159.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 133.2 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 100.8 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 32.3 L 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Most results are within normal limits. Notable findings include mildly low fasting glucose, low total CO₂ (suggesting possible mild metabolic acidosis or compensation), elevated LDL cholesterol, and low HDL cholesterol, indicating increased cardiovascular risk. Recommend clinical correlation for metabolic status and consideration of lipid management. No evidence of renal dysfunction.